Alliancebernstein L.P. I Teos Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 32,510 shares of ITOS stock, worth $267,557. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,510

Previous 38,410 15.36%

Holding current value

$267,557

Previous $570,000 41.93%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.09 - $17.97 $59,531 - $106,023	-5,900 Reduced 15.36%	32,510 $331,000
Q2 2024 Aug 14, 2024	BUY	$10.33 - $18.09 $67,971 - $119,032	6,580 Added 20.67%	38,410 $570,000
Q1 2024 May 14, 2024	SELL	$9.89 - $13.64 $34,516 - $47,603	-3,490 Reduced 9.88%	31,830 $434,000
Q3 2023 Nov 14, 2023	SELL	$10.95 - $14.6 $19,053 - $25,404	-1,740 Reduced 4.7%	35,320 $386,000
Q2 2023 Aug 15, 2023	BUY	$12.93 - $18.05 $152,056 - $212,268	11,760 Added 46.48%	37,060 $490,000
Q1 2023 May 15, 2023	SELL	$13.02 - $22.62 $47,158 - $81,929	-3,622 Reduced 12.52%	25,300 $344,000
Q4 2022 Feb 14, 2023	SELL	$17.77 - $21.6 $779,338 - $947,311	-43,857 Reduced 60.26%	28,922 $564,000
Q3 2022 Nov 15, 2022	SELL	$18.6 - $27.25 $10.4 Million - $15.2 Million	-558,339 Reduced 88.47%	72,779 $1.39 Million
Q2 2022 Aug 15, 2022	SELL	$16.57 - $35.1 $8.06 Million - $17.1 Million	-486,228 Reduced 43.52%	631,118 $13 Million
Q1 2022 May 13, 2022	SELL	$31.92 - $47.45 $6 Million - $8.91 Million	-187,867 Reduced 14.39%	1,117,346 $36 Million
Q4 2021 Feb 14, 2022	SELL	$26.23 - $47.86 $783,437 - $1.43 Million	-29,868 Reduced 2.24%	1,305,213 $60.8 Million
Q3 2021 Nov 10, 2021	SELL	$23.91 - $29.58 $478,128 - $591,511	-19,997 Reduced 1.48%	1,335,081 $36 Million
Q2 2021 Jul 30, 2021	BUY	$17.9 - $36.1 $3.31 Million - $6.68 Million	185,077 Added 15.82%	1,355,078 $34.8 Million
Q1 2021 May 06, 2021	BUY	$30.86 - $44.2 $2.22 Million - $3.18 Million	71,901 Added 6.55%	1,170,001 $40 Million
Q4 2020 Feb 08, 2021	BUY	$21.59 - $33.95 $7.13 Million - $11.2 Million	330,016 Added 42.97%	1,098,100 $37.1 Million
Q3 2020 Nov 12, 2020	BUY	$17.57 - $32.92 $13.5 Million - $25.3 Million	768,084 New	768,084 $18.9 Million

Others Institutions Holding ITOS

# of Institutions

165

Shares Held

36.6M

Call Options Held

1.95M

Put Options Held

374K

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $293M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. I Teos Therapeutics, Inc. Transaction History